A novel TLR7 agonist as adjuvant to stimulate high quality HBsAg-specific immune responses in an HBV mouse model

BACKGROUND: The global burden of hepatitis B virus (HBV) infection in terms of morbidity and mortality is immense. Novel treatments that can induce a protective immune response are urgently needed to effectively control the HBV epidemic and eventually eradicate chronic HBV infection. METHODS: We des...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Transl Med
Autors principals: Hu, Yunlong, Tang, Li, Zhu, Zhengyu, Meng, He, Chen, Tingting, Zhao, Sheng, Jin, Zhenchao, Wang, Zhulin, Jin, Guangyi
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7055022/
https://ncbi.nlm.nih.gov/pubmed/32131853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-020-02275-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars